CINJALL: Treatment for Children With Acute Lymphocytic Leukemia

NCT00176462 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Lymphocytic Leukemia

Interventions

DRUG: aminopterin
DRUG: L-asparaginase
DRUG: cyclophosphamide
DRUG: cytarabine
DRUG: daunomycin
DRUG: dexamethasone
DRUG: 6-mercaptopurine
DRUG: methotrexate
DRUG: 6-thioguanine
DRUG: vincristine
DRUG: Triple Intrathecal Therapy (MTX, Cytarabine, Hydrocortisone)
DRUG: Leucovorin

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]